References

  1. Garcia M, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ: Global Cancer Facts and Figures. 2007 (http://www.cancer.gov), (online). Accessed Aug 20, 2008. Google Scholar

  2. Kim JP, Kim YW, Yang HG, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg. 1994 Nov-Dec; 18(6):872-7. PubMed | Google Scholar

  3. Kajiyama Y, Tsurumaru M, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M, et al. Prognosticfactors in adenocarcinoma of the gastric cardia: pathologic stage analysis and multivariate regression analysis. J Clin Oncol. 1997 May; 15(5): 2015-21. PubMed | Google Scholar

  4. Gunderson LL. Gastric cancer - patterns of relapses aftersurgicalresection. Semin Radiat Oncol. 2002 Apr; 12(2): 150-61. PubMed | Google Scholar

  5. Mc Culloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymphnodes dissection technique for adenocarcinoma of the stomach. Cochrane Database SystRev. 2003;(4) :CD001964. PubMed | Google Scholar

  6. Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric cancer. Int J Radiat Oncol BiolPhys. 1990 Dec;19(6):1357-62. PubMed | Google Scholar

  7. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001 Sep 6; 345(10): 725-30. PubMed | Google Scholar

  8. Landry J, Tepper JE, Wood WC, et al. Analysis of survival and local control following surgery for gastric cancer. Int J RadiatOncolBiolPhys. 1990; 191: 1357. Google Scholar

  9. Macdonald JS, Smalley S, Benedetti J. SWOG; ECOG; RTOG; CALGB; NCCTG. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and GE junction: update of the results of intergroup study INT-0116 (SWOG 9008). San Francisco: ASCO, 2004.

  10. Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adeno-carcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005 Dec; 63(5): 1279-85. PubMed | Google Scholar

  11. Bora H, Unsal D, Akmansu M. Results of chemoirradiation after curative resection of locally advanced gastric cancer. Int J Clin Pract. 2004 May; 58(5): 451-6. PubMed | Google Scholar

  12. Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, et al. Adjuvant radiotherapy and chemotherapy in resectablegastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC. Eur J SurgOncol. 1989 Dec; 15(6): 535-43. PubMed | Google Scholar

  13. Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer. 2004 Jul 5; 91(1): 11-7. PubMed | Google Scholar

  14. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, La- caine F, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a french prospective controlledstudy. Ann Surg. 1989 Feb; 209(2): 162-6. PubMed | Google Scholar

  15. Bollschweiler E, Boettcher K, Hoelscher AH, Sasako M, Kinoshita T, Maruyama K, et al. Preoperative assessment of lymphnode metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg. 1992 Feb; 79(2):156-60. PubMed | Google Scholar

  16. Guadagni S, de Manzoni G, Catarci M, Valenti M, Amicucci G, De Ber- nardinis G, et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymphnode metastases from gastric cancer. World J Surg. 2000 Dec; 24(12): 1550-8. PubMed | Google Scholar

  17. Bora H, Unsal D, Akmansu M. Results of chemoirradiation after curative resection of locally advanced gastric cancer. Int J Clin Pract. 2004 May; 58(5): 451-6. PubMed | Google Scholar

  18. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease - specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003 Oct; 21(19): 3647-50. PubMed | Google Scholar

  19. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al. Italian Research Group for Gastric Cancer (IRGGC): The ratio between metastatic and examined lymphnodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007 Apr; 245(4): 543-52. PubMed | Google Scholar

  20. Wydmanski J. Study of effectiveness and tolerance of pre- and postoperative radiochemotherapy for patients with stomach cancer.Nowotwory J Oncol. 2008; 58: 5-47. Google Scholar

  21. Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Min Surg Oncol. 1994 Jan-Feb; 10(1): 12-20. PubMed | Google Scholar

  22. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005Feb; 241(2): 247-55. PubMed | Google Scholar

  23. Jackson C, Cunningham D, Oliveira J; ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May; 20(Suppl 4): 34-6. PubMed | Google Scholar

  24. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Post- operative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000 Mar; 87(3): 353-7. PubMed | Google Scholar